|
Volumn 45, Issue 12, 2010, Pages 5965-5978
|
Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols
|
Author keywords
(Aryloxy)phenyl cyclopropyl methanol; (Aryloxy)phenyl cyclopropyl methanone; Antitubercular agents; Cytotoxicty; Mycobacterium tuberculosis; Sodium hydride
|
Indexed keywords
3 [2 (PIPERIDIN 1 YL)ETHOXY]PHENYLMETHANOL;
4 (2 MORPHOLINOETHOXY)PHENYLMETHANOL;
4 [2 (DIISOPROPYLAMINO)ETHOXY]PHENYLMETHANOL;
4 [2 (DIMETHYLAMINO)ETHOXY]PHENYLMETHANOL;
4 [2 (PIPERIDIN 1 YL)ETHOXY]PHENYLMETHANOL;
[4 (3 BROMOBENZYLOXY)PHENYL](CYCLOPROPYL)METHANOL;
[4 (3 BROMOBENZYLOXY)PHENYL](CYCLOPROPYL)METHANONE;
[4 (4 BROMOBENZYLOXY)PHENYL](CYCLOPROPYL)METHANOL;
[4 (4 BROMOBENZYLOXY)PHENYL](CYCLOPROPYL)METHANONE;
[4 [2 (N,N DIBUTYLAMINO)ETHOXY]PHENYL]CYCLOPROPYLMETHANONE;
[4 [4 (BENZYLOXY)BENZYLOXY]PHENYL](CYCLOPROPYL)METHANONE;
CYCLOPROPYL[4 (3 NITROBENZYLOXY)PHENYL]METHANOL;
CYCLOPROPYL[4 (3 NITROBENZYLOXY)PHENYL]METHANONE;
CYCLOPROPYL[4 (3,4,5 TRIMETHOXYBENZYLOXY)PHENYL]METHANOL;
CYCLOPROPYL[4 (3,4,5 TRIMETHOXYBENZYLOXY)PHENYL]METHANONE;
CYCLOPROPYL[4 [3 (2 PIPERIDIN 1 YLETHOXY)BENZYLOXY]PHENYL]METHANOL;
CYCLOPROPYL[4 [3 (3,4 DICHLOROBENZYLOXY)BENZYLOXY]PHENYL]METHANOL;
CYCLOPROPYL[4 [3 (3,4 DICHLOROBENZYLOXY)BENZYLOXY]PHENYL]METHANONE;
CYCLOPROPYL[4 [4 (2 (DIMETHYLAMINO)ETHOXOY]BENZYLOXY]PHENYLMETHANONE;
CYCLOPROPYL[4 [4 (2 DIISOPROPYLAMINO)ETHOXY]BENZYLOXY]PHENYLMETHANONE;
CYCLOPROPYL[4 [4 (2 MORPHOLIN 4 YLETHOXY)BENZYLOXY]PHENYL]METHANOL;
CYCLOPROPYL[4 [4 (2 MORPHOLIN 4 YLETHOXY)BENZYLOXY]PHENYL]METHANONE;
CYCLOPROPYL[4 [4 (2 PIPERIDIN 1 YLETHOXY)BENZYLOXY]PHENYL]METHANONE;
CYCLOPROPYL[4 [4 (PYRIDIN 2 YLMETHOXY)BENZYLOXY]PHENYL]METHANOL;
CYCLOPROPYL[4 [4 [2 (DIMETHYLAMINO)ETHOXY]BENZYLOXY]PHENYL]METHANOL;
ISONIAZID;
METHANOL DERIVATIVE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG EFFICACY;
DRUG SCREENING;
DRUG STABILITY;
DRUG SYNTHESIS;
MACROPHAGE;
MINIMUM INHIBITORY CONCENTRATION;
MOUSE;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
THERMOSTABILITY;
ANIMALS;
ANTITUBERCULAR AGENTS;
CERCOPITHECUS AETHIOPS;
CYCLOPROPANES;
FEMALE;
MACROPHAGES;
METHANOL;
MICE;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
MYCOBACTERIUM TUBERCULOSIS;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
VERO CELLS;
|
EID: 78649328348
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2010.09.063 Document Type: Article |
Times cited : (7)
|
References (30)
|